Surviving Pneumonia

Recruiting

• Conditions: Community-acquired Pneumonia
• Interventions: Other: No intervention

• Registration Number: NCT03795662
• Lead Sponsor: Nordsjaellands Hospital

Brief Summary

The study aims to explore risk factors for poor prognosis among patients admitted with community-acquired pneumonia (CAP). During a 5-year study period, all patients (aged ≥ 18 years) admitted with CAP at North Zealand Hospital will be invited for inclusion. Questionnaires, anthropometric measures, laboratory tests, and biomaterials will be collected at admission, daily during admission, at discharge and at follow-up. The main clinical outcomes of the study consist of deaths and development of diabetes.

Detailed Description

Not available

Study Timeline

• Study First Submitted: 2018-11-09
• Study First Submitted QC: 2019-01-03
• Study Start: 2019-01-07
• Study First Posted: 2019-01-08
• Status Verified: 2021-04
• Last Update Submitted: 2021-04-28
• Last Update Posted: 2021-04-29
• Primary Completion: 2023-12-31
• Study Completion: 2038-12-31

Recruitment & Eligibility

• Status: RECRUITING
• Sex: All
• Target Recruitment: 2500

Inclusion Criteria

• Infiltrate on chest radiograph plus one or more of the following:

  • Fever (temperature, ≥38.0°C)
  • Hypothermia (<35.0°C),
  • New cough with or without sputum production
  • Pleuritic chest pain
  • Dyspnea
  • Altered breath sounds on auscultation.

Exclusion Criteria

• Patients unable to give informed consent
• Patients unwilling to give informed consent

Study & Design

• Study Type: OBSERVATIONAL
• Study Design: Not specified

Arm && Interventions

Group	Intervention	Description
Community-acquired pneumonia	No intervention	Adults over 18 years old admitted with confirmed community-acquired pneumonia.

Primary Outcome Measures

Name	Time	Method
Number of death from any causes	From date of admission until the day of death from any causes, up to 24 months	Assessed through patient files
Number of participants who develop diabetes	Up to 24 months	Assessed through patient files and the national registers

Secondary Outcome Measures

Name	Time	Method
Oral glucose tolerance test	Day 1, discharge (an average of 5 days), 1 month and 6-month
Number of participants who are readmitted	Up to 6 months	Through patient files
Length of hospital stay	Participants will be followed for the duration of hospital stay, an expected average of 5 days	Through patient files

Trial Locations

Locations (1)

Department of Pulmonary and Infectious Diseases, Nordsjællands Hospital; 🇩🇰 Hillerød, Denmark